Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy
- Institution
- CEDARS-SINAI MEDICAL CENTER, CA
- Principal investigator
- Ophir D Klein
- Funding
- $2.0M
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
ABSTRACT Fetal reversion is a novel regenerative phenomenon in which cells of the intestinal epithelium respond to damage by downregulating the normal gene expression program observed during homeostasis and by acquiring a fetal- like transcriptional state that promotes cell proliferation and intestinal repair. Fetal reversion has been observed in different intestinal injury models in the mouse, including damage from parasitic or viral infection, radiation, and chemical insults. It is unknown if fetal reversion is a universal property of intestinal healing or if it occurs only during certain types of repair. Recent evidence indicates that this phenomenon may also occur in the human intestine; however, this has also not been interrogated in a systematic way. This project will create a unique large-scale research resource – an atlas of intestinal injury across multiple species (mouse, human) and damage models that contains comprehensive single cell multiomic datasets of regulatory and transcriptional dynamics during intestinal repair after injury. The atlas will be a tool for future hypothesis generation for functional studies and will be an important community-wide resource available to the entire scientific community. Genes and pathways essential for fetal reversion, and for any other common intestinal regeneration programs, will be identified using atlas data. Functional studies to explore pathways and genes will be conducted in mouse models through gain- and loss-of-function experiments and will be interrogated in the human context using intestinal organoids as a model system. A high-throughput drug screening assay will be used to identify compounds that induce fetal reversion, and top compounds identified will be assessed for their ability to induce the fetal reversion state through transcriptomic and epigenomic assays, and to enhance organoid-engraftment and injury repair in vivo through transplantation assays. This project will create a multi-species injury-repair atlas and comprehensively characterize different modes of intestinal regeneration, including fetal reversion, providing an unprecedented understanding of intestinal injury- repair. All data, analyses, methods, models and screening protocols will be shared with the research community for exploration and further analysis following established sharing models. The studies proposed here will identify common and unique regenerative programs that are active in different injury contexts, creating a paradigm shift in our understanding of gut repair, and laying the foundation for new fields of research and therapeutics.
Research team
- Sarah E BluttPI
- Dario BoffelliPI
- Ophir D KleinPI
- Jason SpencePI
- Michael P. VerziPI
LOADING MOONBASE SCORE
Questions for CEDARS-SINAI MEDICAL CENTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Cedars-Sinai Medical CenterNot yet scored
Mechanisms of hyperactive Ras signaling in craniofacial and dental diseases
Jeffrey Ohmann Bush · $600K · 2025–2030
- NIH · Intero Biosystems Inc.Not yet scored
A Novel Multi-Lineage Human Intestinal Organoid Screening Platform for Drug Discovery and Preclinical Testing
Charlie Childs · $350K · 2025–2026
- NIH · Cedars-Sinai Medical CenterNot yet scored
A Team Science Approach to the Co Development of Oral Mucosa for Therapeutic Purposes
Kevin Matthew Byrd · $1.2M · 2025–2030